Skip to content

Clinical trials

Active, not recruiting Neoplasm Metastasis trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Active, not recruiting Country / region: Russia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20161
20181
20192
20201
20217
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Eli Lilly and Company2
AbbVie1
Genentech, Inc.1
Institut de Recherches Internationales Servier1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
Tomsk National Research Medical Center of the Russian Academy of Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis15
Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Breast Diseases3
Colorectal Neoplasms2
Neoplasms by Site2
Biliary Tract Neoplasms1
Carcinoma1
Lung Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.